HIV-1 Tat and Immune Dysregulation in AIDS Pathogenesis: A Therapeutic Target

被引：11

作者：

Chiozzini, Chiara ^{[1
]}

Toschi, Elena ^{[2
]}

机构：

[1] Ist Super Sanita, Natl AIDS Ctr, I-00161 Rome, Italy

[2] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy

来源：

CURRENT DRUG TARGETS | 2016年 / 17卷 / 01期

关键词：

AIDS pathogenesis; immune dysregulation; HIV-1; Tat; therapy; vaccine; HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; RECEPTOR-RELATED PROTEIN; 2ND CODING EXON; T-CELLS; KAPOSIS-SARCOMA; DENDRITIC CELLS; GROWTH-FACTOR; GENE-THERAPY; IN-VIVO;

D O I：

10.2174/1389450116666150825110658

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The HIV-1 transactivator Tat protein plays a key role in AIDS pathogenesis. Besides the Tat role as activator of HIV-1 transcription, it exerts several important functions on infected and uninfected cells. In fact, HIV-1 Tat is released by infected cells and is taken up by neighboring cells. In this way it regulates expression of viral and cellular genes and it modulates several cellular pathways leading to HIV-1 infection spreading and immune dysregulation. So far, Tat protein and the cellular pathways targeted by Tat may represent potential targets for new anti-HIV therapeutic approaches and vaccine development against AIDS.

引用

页码：33 / 45

页数：13

共 50 条

[41] In vitro selection of HIV-1 TAR variants by the Tat protein [J].

Marozzi, A ;

Meneveri, R ;

Giacca, M ;

Gutierrez, MI ;

Siccardi, AG ;

Ginelli, E .

JOURNAL OF BIOTECHNOLOGY, 1998, 61 (02) :117-128

[42] Characterization of HIV-1 Tat proteins mutated in the transactivation domain for prophylactic and therapeutic application [J].

Betti, M ;

Voltan, R ;

Marchisio, M ;

Mantovani, I ;

Boarini, C ;

Nappi, F ;

Ensoli, B ;

Caputo, A .

VACCINE, 2001, 19 (25-26) :3408-3419

[43] HIV-1 Pathogenesis: The Virus [J].

Swanstrom, Ronald ;

Coffin, John .

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (12)

[44] Coreceptors and HIV-1 pathogenesis [J].

Gorry P.R. ;

Ancuta P. .

Current HIV/AIDS Reports, 2011, 8 (1) :45-53

[45] Immune control of HIV-1 reservoirs [J].

Autran, Brigitte ;

Descours, Benjamin ;

Bacchus, Charline .

CURRENT OPINION IN HIV AND AIDS, 2013, 8 (03) :204-210

[46] Endocannabinoids affect innate immunity of Muller glia during HIV-1 Tat cytotoxicity [J].

Krishnan, Gopinath ;

Chatterjee, Nivedita .

MOLECULAR AND CELLULAR NEUROSCIENCE, 2014, 59 :10-23

[47] The evolution of subtype B HIV-1 tat in the Netherlands during 1985-2012 [J].

van der Kuyl, Antoinette C. ;

Vink, Monique ;

Zorgdrager, Fokla ;

Bakker, Margreet ;

Wymant, Chris ;

Hall, Matthew ;

Gall, Astrid ;

Blanquart, Francois ;

Berkhout, Ben ;

Fraser, Christophe ;

Cornelissen, Marion .

VIRUS RESEARCH, 2018, 250 :51-64

[48] AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection [J].

Lawn, SD .

JOURNAL OF INFECTION, 2004, 48 (01) :1-12

[49] Role of HIV-1 Tat and CC Chemokine MIP-1α in the pathogenesis of HIV associated central nervous system disorders [J].

Bonwetsch, R ;

Croul, S ;

Richardson, MW ;

Lorenzana, C ;

Del Valle, L ;

Sverstiuk, AE ;

Amini, S ;

Morgello, S ;

Khalili, K ;

Rappaport, J .

JOURNAL OF NEUROVIROLOGY, 1999, 5 (06) :685-694

[50] Comparative analysis of HIV-1 Tat variants [J].

Pantano, S ;

Carloni, P .

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2005, 58 (03) :638-643

← 1 2 3 4 5 →